Case report: Primary ovarian Burkitt's lymphoma: A puzzling scenario in pediatric population.
burkitt’s lymphoma
lymphoma
ovarian cancer
pediatrics
surgery
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2022
2022
Historique:
received:
17
10
2022
accepted:
15
12
2022
entrez:
30
1
2023
pubmed:
31
1
2023
medline:
31
1
2023
Statut:
epublish
Résumé
Burkitt's lymphoma (BL) is defined as a highly invasive B-cell lymphoma, usually characterized by an excellent prognosis, more than 90% of children and adolescents being cured with highly dose-intensive multiagent chemotherapy. Primary ovarian localization without involvement of other organs is a rare manifestation of BL, especially in pediatric population. Symptoms at diagnosis are similar to other ovarian lesions and differential diagnosis may be challenging for clinicians. A 12-year-old girl was referred to our institution for abdominal pain and palpable mass observed by the pediatrician. Diagnostic work-up demonstrated a large mass arising from the right ovary, causing compression on abdominal aorta, inferior vena cava, ureters and bowel, with a second smaller lesion on the left ovary. At surgery, a 15 cm-large, ruptured mass arising from the right ovary was found, associated with a second lesion originating from the left ovary (8 cm) and multiple nodules of the greater omentum. Right salpingo-oophorectomy was performed, incisional biopsies were taken from the left ovary and omental nodules and peritoneal fluid samples were collected for cytology. Pathology revealed a Burkitt lymphoma and the patient underwent chemotherapy according to AIEOP LNH-97 Protocol, group R3 with
Identifiants
pubmed: 36714645
doi: 10.3389/fped.2022.1072567
pmc: PMC9875037
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1072567Informations de copyright
© 2023 Persano, Crocoli, Martucci, Vinti, Cassanelli, Stracuzzi, Cardoni and Inserra.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Pediatr Radiol. 2021 Mar;51(3):427-434
pubmed: 33185738
N Engl J Med. 2022 Sep 22;387(12):1111-1122
pubmed: 36129999
Semin Pediatr Surg. 2006 Feb;15(1):30-6
pubmed: 16458844
Int J Surg Case Rep. 2021 Jun;83:105904
pubmed: 34051445
Am J Surg Pathol. 2013 Apr;37(4):548-53
pubmed: 23388124
Acta Haematol. 2013;129(3):169-74
pubmed: 23257666
Arch Gynecol Obstet. 2017 Oct;296(4):653-660
pubmed: 28770352
J Obstet Gynaecol Res. 2013 Aug;39(8):1363-6
pubmed: 23800271
Radiographics. 2014 Nov-Dec;34(7):2039-55
pubmed: 25384300
Br J Haematol. 2010 May;149(4):578-86
pubmed: 20331465
N Engl J Med. 2013 Nov 14;369(20):1915-25
pubmed: 24224624
Br J Haematol. 2016 Nov;175(3):467-475
pubmed: 27392319
Radiol Med. 1998 May;95(5):493-7
pubmed: 9687927
Am J Surg Pathol. 2005 Aug;29(8):1086-94
pubmed: 16006805
Biomarkers. 2021 May;26(3):268-274
pubmed: 33554683
J Clin Oncol. 1997 Feb;15(2):594-603
pubmed: 9053482
J Indian Assoc Pediatr Surg. 2014 Oct;19(4):189-94
pubmed: 25336799
J Clin Oncol. 2020 Aug 1;38(22):2519-2529
pubmed: 32453640
J Surg Res. 2009 Sep;156(1):45-9
pubmed: 19592022
Lancet Oncol. 2016 Apr;17(4):e149-e162
pubmed: 27300675
J Pediatr Adolesc Gynecol. 2015 Dec;28(6):441-6
pubmed: 26220350
Adv Anat Pathol. 2001 Jul;8(4):200-17
pubmed: 11444509
Ecancermedicalscience. 2022 Feb 17;16:1356
pubmed: 35510137
Adolesc Health Med Ther. 2016 Dec 23;8:11-29
pubmed: 28096698
J Clin Oncol. 2015 Jun 20;33(18):2112-8
pubmed: 25940716
Clin Case Rep. 2021 Nov 09;9(11):e05058
pubmed: 34786198